Zoryve Normalized: zoryve |
Drug |
Arcutis Biotherapeutics, Inc. |
$108,634.53 |
77 |
2025 |
Source payment records
-
2025-02-14 · Arcutis Biotherapeutics, Inc. · $3,000.00 ·
Open Payments source
-
2025-02-26 · Arcutis Biotherapeutics, Inc. · $1,500.00 ·
Open Payments source
-
2025-03-25 · Arcutis Biotherapeutics, Inc. · $12.98 ·
Open Payments source
-
2025-04-11 · Arcutis Biotherapeutics, Inc. · $5,250.00 ·
Open Payments source
-
2025-04-23 · Arcutis Biotherapeutics, Inc. · $125.00 ·
Open Payments source
-
2025-05-16 · Arcutis Biotherapeutics, Inc. · $3,000.00 ·
Open Payments source
-
2025-05-23 · Arcutis Biotherapeutics, Inc. · $218.02 ·
Open Payments source
-
2025-05-23 · Arcutis Biotherapeutics, Inc. · $218.03 ·
Open Payments source
-
2025-05-30 · Arcutis Biotherapeutics, Inc. · $1,129.36 ·
Open Payments source
-
2025-05-30 · Arcutis Biotherapeutics, Inc. · $5,625.00 ·
Open Payments source
-
2025-05-30 · Arcutis Biotherapeutics, Inc. · $3,000.00 ·
Open Payments source
-
2025-05-30 · Arcutis Biotherapeutics, Inc. · $719.10 ·
Open Payments source
-
2025-06-20 · Arcutis Biotherapeutics, Inc. · $303.97 ·
Open Payments source
-
2025-06-21 · Arcutis Biotherapeutics, Inc. · $92.08 ·
Open Payments source
-
2025-06-21 · Arcutis Biotherapeutics, Inc. · $138.91 ·
Open Payments source
-
2025-06-21 · Arcutis Biotherapeutics, Inc. · $271.35 ·
Open Payments source
-
2025-06-21 · Arcutis Biotherapeutics, Inc. · $103.10 ·
Open Payments source
-
2025-06-24 · Arcutis Biotherapeutics, Inc. · $70.84 ·
Open Payments source
-
2025-06-26 · Arcutis Biotherapeutics, Inc. · $184.17 ·
Open Payments source
-
2025-06-26 · Arcutis Biotherapeutics, Inc. · $608.64 ·
Open Payments source
-
2025-06-26 · Arcutis Biotherapeutics, Inc. · $124.97 ·
Open Payments source
-
2025-06-26 · Arcutis Biotherapeutics, Inc. · $184.16 ·
Open Payments source
-
2025-06-26 · Arcutis Biotherapeutics, Inc. · $443.27 ·
Open Payments source
-
2025-06-26 · Arcutis Biotherapeutics, Inc. · $184.16 ·
Open Payments source
-
2025-06-26 · Arcutis Biotherapeutics, Inc. · $814.06 ·
Open Payments source
-
2025-06-27 · Arcutis Biotherapeutics, Inc. · $6,000.00 ·
Open Payments source
-
2025-06-27 · Arcutis Biotherapeutics, Inc. · $467.11 ·
Open Payments source
-
2025-06-27 · Arcutis Biotherapeutics, Inc. · $3,375.00 ·
Open Payments source
-
2025-06-27 · Arcutis Biotherapeutics, Inc. · $3,000.00 ·
Open Payments source
-
2025-07-09 · Arcutis Biotherapeutics, Inc. · $6,000.00 ·
Open Payments source
-
2025-07-09 · Arcutis Biotherapeutics, Inc. · $3,750.00 ·
Open Payments source
-
2025-08-25 · Arcutis Biotherapeutics, Inc. · $20.75 ·
Open Payments source
-
2025-08-26 · Arcutis Biotherapeutics, Inc. · $11.86 ·
Open Payments source
-
2025-09-02 · Arcutis Biotherapeutics, Inc. · $117.54 ·
Open Payments source
-
2025-09-13 · Arcutis Biotherapeutics, Inc. · $269.11 ·
Open Payments source
-
2025-09-19 · Arcutis Biotherapeutics, Inc. · $150.00 ·
Open Payments source
-
2025-09-25 · Arcutis Biotherapeutics, Inc. · $947.30 ·
Open Payments source
-
2025-09-26 · Arcutis Biotherapeutics, Inc. · $5,625.00 ·
Open Payments source
-
2025-09-26 · Arcutis Biotherapeutics, Inc. · $151.47 ·
Open Payments source
-
2025-09-26 · Arcutis Biotherapeutics, Inc. · $151.47 ·
Open Payments source
-
2025-10-04 · Arcutis Biotherapeutics, Inc. · $182.74 ·
Open Payments source
-
2025-10-04 · Arcutis Biotherapeutics, Inc. · $182.73 ·
Open Payments source
-
2025-10-07 · Arcutis Biotherapeutics, Inc. · $199.76 ·
Open Payments source
-
2025-10-07 · Arcutis Biotherapeutics, Inc. · $199.76 ·
Open Payments source
-
2025-10-09 · Arcutis Biotherapeutics, Inc. · $546.20 ·
Open Payments source
-
2025-10-09 · Arcutis Biotherapeutics, Inc. · $159.38 ·
Open Payments source
-
2025-10-10 · Arcutis Biotherapeutics, Inc. · $598.98 ·
Open Payments source
-
2025-10-10 · Arcutis Biotherapeutics, Inc. · $6,375.00 ·
Open Payments source
-
2025-10-15 · Arcutis Biotherapeutics, Inc. · $434.86 ·
Open Payments source
-
2025-10-15 · Arcutis Biotherapeutics, Inc. · $155.37 ·
Open Payments source
-
2025-10-15 · Arcutis Biotherapeutics, Inc. · $3,375.00 ·
Open Payments source
-
2025-10-17 · Arcutis Biotherapeutics, Inc. · $947.30 ·
Open Payments source
-
2025-10-21 · Arcutis Biotherapeutics, Inc. · $1,005.36 ·
Open Payments source
-
2025-10-22 · Arcutis Biotherapeutics, Inc. · $3,375.00 ·
Open Payments source
-
2025-11-04 · Arcutis Biotherapeutics, Inc. · $137.26 ·
Open Payments source
-
2025-11-07 · Arcutis Biotherapeutics, Inc. · $5.06 ·
Open Payments source
-
2025-11-07 · Arcutis Biotherapeutics, Inc. · $4.27 ·
Open Payments source
-
2025-11-14 · Arcutis Biotherapeutics, Inc. · $1,875.00 ·
Open Payments source
-
2025-11-14 · Arcutis Biotherapeutics, Inc. · $311.05 ·
Open Payments source
-
2025-11-14 · Arcutis Biotherapeutics, Inc. · $544.96 ·
Open Payments source
-
2025-11-14 · Arcutis Biotherapeutics, Inc. · $290.91 ·
Open Payments source
-
2025-11-14 · Arcutis Biotherapeutics, Inc. · $161.63 ·
Open Payments source
-
2025-11-18 · Arcutis Biotherapeutics, Inc. · $189.34 ·
Open Payments source
-
2025-11-19 · Arcutis Biotherapeutics, Inc. · $141.40 ·
Open Payments source
-
2025-11-19 · Arcutis Biotherapeutics, Inc. · $92.43 ·
Open Payments source
-
2025-11-19 · Arcutis Biotherapeutics, Inc. · $92.43 ·
Open Payments source
-
2025-11-19 · Arcutis Biotherapeutics, Inc. · $5,625.00 ·
Open Payments source
-
2025-11-19 · Arcutis Biotherapeutics, Inc. · $773.80 ·
Open Payments source
-
2025-11-19 · Arcutis Biotherapeutics, Inc. · $5,625.00 ·
Open Payments source
-
2025-11-19 · Arcutis Biotherapeutics, Inc. · $92.43 ·
Open Payments source
-
2025-11-19 · Arcutis Biotherapeutics, Inc. · $92.43 ·
Open Payments source
-
2025-11-20 · Arcutis Biotherapeutics, Inc. · $467.83 ·
Open Payments source
-
2025-11-20 · Arcutis Biotherapeutics, Inc. · $517.08 ·
Open Payments source
-
2025-12-13 · Arcutis Biotherapeutics, Inc. · $3,375.00 ·
Open Payments source
-
2025-12-13 · Arcutis Biotherapeutics, Inc. · $3,375.00 ·
Open Payments source
-
2025-12-13 · Arcutis Biotherapeutics, Inc. · $6,375.00 ·
Open Payments source
-
2025-12-17 · Arcutis Biotherapeutics, Inc. · $3,375.00 ·
Open Payments source
|
NEMLUVIO Normalized: nemluvio |
Drug |
Galderma Laboratories, L.P. |
$100,776.14 |
63 |
2025 |
Source payment records
-
2025-03-04 · Galderma Laboratories, L.P. · $38.68 ·
Open Payments source
-
2025-03-04 · Galderma Laboratories, L.P. · $30.00 ·
Open Payments source
-
2025-03-04 · Galderma Laboratories, L.P. · $356.78 ·
Open Payments source
-
2025-03-12 · Galderma Laboratories, L.P. · $3,600.00 ·
Open Payments source
-
2025-03-20 · Galderma Laboratories, L.P. · $148.97 ·
Open Payments source
-
2025-03-20 · Galderma Laboratories, L.P. · $1,016.28 ·
Open Payments source
-
2025-03-20 · Galderma Laboratories, L.P. · $50.00 ·
Open Payments source
-
2025-03-20 · Galderma Laboratories, L.P. · $575.46 ·
Open Payments source
-
2025-03-20 · Galderma Laboratories, L.P. · $411.20 ·
Open Payments source
-
2025-03-26 · Galderma Laboratories, L.P. · $3,600.00 ·
Open Payments source
-
2025-03-26 · Galderma Laboratories, L.P. · $9,300.00 ·
Open Payments source
-
2025-03-27 · Galderma Laboratories, L.P. · $131.89 ·
Open Payments source
-
2025-03-27 · Galderma Laboratories, L.P. · $302.89 ·
Open Payments source
-
2025-03-27 · Galderma Laboratories, L.P. · $240.01 ·
Open Payments source
-
2025-03-27 · Galderma Laboratories, L.P. · $30.00 ·
Open Payments source
-
2025-03-27 · Galderma Laboratories, L.P. · $655.98 ·
Open Payments source
-
2025-03-28 · Galderma Laboratories, L.P. · $16.05 ·
Open Payments source
-
2025-04-02 · Galderma Laboratories, L.P. · $2,250.00 ·
Open Payments source
-
2025-04-02 · Galderma Laboratories, L.P. · $8,100.00 ·
Open Payments source
-
2025-05-12 · Galderma Laboratories, L.P. · $2,250.00 ·
Open Payments source
-
2025-05-16 · Galderma Laboratories, L.P. · $16.01 ·
Open Payments source
-
2025-07-15 · Galderma Laboratories, L.P. · $33.29 ·
Open Payments source
-
2025-07-15 · Galderma Laboratories, L.P. · $131.87 ·
Open Payments source
-
2025-07-15 · Galderma Laboratories, L.P. · $597.56 ·
Open Payments source
-
2025-07-15 · Galderma Laboratories, L.P. · $981.34 ·
Open Payments source
-
2025-07-15 · Galderma Laboratories, L.P. · $30.00 ·
Open Payments source
-
2025-07-15 · Galderma Laboratories, L.P. · $817.70 ·
Open Payments source
-
2025-07-18 · Galderma Laboratories, L.P. · $2,250.00 ·
Open Payments source
-
2025-07-23 · Galderma Laboratories, L.P. · $3,600.00 ·
Open Payments source
-
2025-07-23 · Galderma Laboratories, L.P. · $9,300.00 ·
Open Payments source
-
2025-08-01 · Galderma Laboratories, L.P. · $600.00 ·
Open Payments source
-
2025-08-06 · Galderma Laboratories, L.P. · $86.47 ·
Open Payments source
-
2025-08-07 · Galderma Laboratories, L.P. · $134.08 ·
Open Payments source
-
2025-08-07 · Galderma Laboratories, L.P. · $152.59 ·
Open Payments source
-
2025-08-07 · Galderma Laboratories, L.P. · $932.40 ·
Open Payments source
-
2025-08-07 · Galderma Laboratories, L.P. · $30.00 ·
Open Payments source
-
2025-08-07 · Galderma Laboratories, L.P. · $200.81 ·
Open Payments source
-
2025-08-15 · Galderma Laboratories, L.P. · $8,100.00 ·
Open Payments source
-
2025-09-09 · Galderma Laboratories, L.P. · $138.91 ·
Open Payments source
-
2025-09-09 · Galderma Laboratories, L.P. · $30.00 ·
Open Payments source
-
2025-09-09 · Galderma Laboratories, L.P. · $292.01 ·
Open Payments source
-
2025-09-09 · Galderma Laboratories, L.P. · $817.70 ·
Open Payments source
-
2025-09-11 · Galderma Laboratories, L.P. · $49.77 ·
Open Payments source
-
2025-09-22 · Galderma Laboratories, L.P. · $8,100.00 ·
Open Payments source
-
2025-10-15 · Galderma Laboratories, L.P. · $143.88 ·
Open Payments source
-
2025-10-15 · Galderma Laboratories, L.P. · $43.04 ·
Open Payments source
-
2025-10-15 · Galderma Laboratories, L.P. · $695.50 ·
Open Payments source
-
2025-10-15 · Galderma Laboratories, L.P. · $61.98 ·
Open Payments source
-
2025-10-15 · Galderma Laboratories, L.P. · $977.46 ·
Open Payments source
-
2025-10-15 · Galderma Laboratories, L.P. · $30.00 ·
Open Payments source
-
2025-10-15 · Galderma Laboratories, L.P. · $678.50 ·
Open Payments source
-
2025-10-24 · Galderma Laboratories, L.P. · $9,300.00 ·
Open Payments source
-
2025-10-24 · Galderma Laboratories, L.P. · $5,400.00 ·
Open Payments source
-
2025-11-13 · Galderma Laboratories, L.P. · $147.61 ·
Open Payments source
-
2025-11-18 · Galderma Laboratories, L.P. · $30.00 ·
Open Payments source
-
2025-11-18 · Galderma Laboratories, L.P. · $749.26 ·
Open Payments source
-
2025-11-19 · Galderma Laboratories, L.P. · $754.80 ·
Open Payments source
-
2025-11-19 · Galderma Laboratories, L.P. · $244.80 ·
Open Payments source
-
2025-11-19 · Galderma Laboratories, L.P. · $30.00 ·
Open Payments source
-
2025-11-21 · Galderma Laboratories, L.P. · $132.61 ·
Open Payments source
-
2025-12-01 · Galderma Laboratories, L.P. · $5,400.00 ·
Open Payments source
-
2025-12-01 · Galderma Laboratories, L.P. · $5,400.00 ·
Open Payments source
-
2025-12-10 · Galderma Laboratories, L.P. · $30.00 ·
Open Payments source
|
Bimzelx Normalized: bimzelx |
Biological |
UCB, Inc. |
$92,896.57 |
90 |
2025 |
Source payment records
-
2025-01-03 · UCB, Inc. · $40.88 ·
Open Payments source
-
2025-01-03 · UCB, Inc. · $58.74 ·
Open Payments source
-
2025-01-03 · UCB, Inc. · $85.00 ·
Open Payments source
-
2025-01-03 · UCB, Inc. · $127.23 ·
Open Payments source
-
2025-01-03 · UCB, Inc. · $333.16 ·
Open Payments source
-
2025-01-04 · UCB, Inc. · $35.00 ·
Open Payments source
-
2025-01-04 · UCB, Inc. · $66.21 ·
Open Payments source
-
2025-01-04 · UCB, Inc. · $70.00 ·
Open Payments source
-
2025-01-04 · UCB, Inc. · $86.07 ·
Open Payments source
-
2025-01-07 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-01-28 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-03-18 · UCB, Inc. · $10.00 ·
Open Payments source
-
2025-03-18 · UCB, Inc. · $10.00 ·
Open Payments source
-
2025-03-18 · UCB, Inc. · $10.00 ·
Open Payments source
-
2025-03-20 · UCB, Inc. · $8.75 ·
Open Payments source
-
2025-03-20 · UCB, Inc. · $8.75 ·
Open Payments source
-
2025-03-20 · UCB, Inc. · $8.75 ·
Open Payments source
-
2025-03-23 · UCB, Inc. · $105.09 ·
Open Payments source
-
2025-03-24 · UCB, Inc. · $105.09 ·
Open Payments source
-
2025-03-24 · UCB, Inc. · $105.09 ·
Open Payments source
-
2025-03-24 · UCB, Inc. · $105.09 ·
Open Payments source
-
2025-03-24 · UCB, Inc. · $123.78 ·
Open Payments source
-
2025-03-24 · UCB, Inc. · $400.00 ·
Open Payments source
-
2025-03-24 · UCB, Inc. · $400.00 ·
Open Payments source
-
2025-03-25 · UCB, Inc. · $6.25 ·
Open Payments source
-
2025-03-25 · UCB, Inc. · $8.75 ·
Open Payments source
-
2025-03-25 · UCB, Inc. · $10.00 ·
Open Payments source
-
2025-03-25 · UCB, Inc. · $464.00 ·
Open Payments source
-
2025-03-25 · UCB, Inc. · $574.00 ·
Open Payments source
-
2025-03-26 · UCB, Inc. · $41.25 ·
Open Payments source
-
2025-03-26 · UCB, Inc. · $41.25 ·
Open Payments source
-
2025-03-26 · UCB, Inc. · $41.25 ·
Open Payments source
-
2025-03-26 · UCB, Inc. · $41.25 ·
Open Payments source
-
2025-04-17 · UCB, Inc. · $6.25 ·
Open Payments source
-
2025-04-17 · UCB, Inc. · $6.25 ·
Open Payments source
-
2025-04-17 · UCB, Inc. · $6.25 ·
Open Payments source
-
2025-04-18 · UCB, Inc. · $5.00 ·
Open Payments source
-
2025-04-18 · UCB, Inc. · $5.00 ·
Open Payments source
-
2025-04-18 · UCB, Inc. · $5.00 ·
Open Payments source
-
2025-04-18 · UCB, Inc. · $10.00 ·
Open Payments source
-
2025-04-18 · UCB, Inc. · $10.00 ·
Open Payments source
-
2025-04-18 · UCB, Inc. · $10.00 ·
Open Payments source
-
2025-04-22 · UCB, Inc. · $58.11 ·
Open Payments source
-
2025-04-22 · UCB, Inc. · $58.11 ·
Open Payments source
-
2025-04-22 · UCB, Inc. · $58.11 ·
Open Payments source
-
2025-04-22 · UCB, Inc. · $75.74 ·
Open Payments source
-
2025-04-22 · UCB, Inc. · $92.00 ·
Open Payments source
-
2025-04-22 · UCB, Inc. · $305.39 ·
Open Payments source
-
2025-04-22 · UCB, Inc. · $305.39 ·
Open Payments source
-
2025-04-22 · UCB, Inc. · $305.40 ·
Open Payments source
-
2025-04-23 · UCB, Inc. · $23.43 ·
Open Payments source
-
2025-04-23 · UCB, Inc. · $35.18 ·
Open Payments source
-
2025-04-23 · UCB, Inc. · $296.43 ·
Open Payments source
-
2025-04-23 · UCB, Inc. · $296.43 ·
Open Payments source
-
2025-04-23 · UCB, Inc. · $296.43 ·
Open Payments source
-
2025-04-29 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-04-29 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-04-29 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-04-29 · UCB, Inc. · $7,000.00 ·
Open Payments source
-
2025-05-05 · UCB, Inc. · $2,075.00 ·
Open Payments source
-
2025-05-05 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-05-05 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-05-05 · UCB, Inc. · $7,000.00 ·
Open Payments source
-
2025-05-20 · UCB, Inc. · $49.27 ·
Open Payments source
-
2025-06-02 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-06-03 · UCB, Inc. · $19.71 ·
Open Payments source
-
2025-06-03 · UCB, Inc. · $22.50 ·
Open Payments source
-
2025-06-03 · UCB, Inc. · $22.50 ·
Open Payments source
-
2025-06-03 · UCB, Inc. · $22.50 ·
Open Payments source
-
2025-06-03 · UCB, Inc. · $22.50 ·
Open Payments source
-
2025-06-10 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-06-24 · UCB, Inc. · $4,648.00 ·
Open Payments source
-
2025-06-24 · UCB, Inc. · $4,648.00 ·
Open Payments source
-
2025-07-29 · UCB, Inc. · $4,500.00 ·
Open Payments source
-
2025-08-01 · UCB, Inc. · $46.95 ·
Open Payments source
-
2025-08-01 · UCB, Inc. · $106.07 ·
Open Payments source
-
2025-08-01 · UCB, Inc. · $125.00 ·
Open Payments source
-
2025-08-01 · UCB, Inc. · $211.60 ·
Open Payments source
-
2025-08-01 · UCB, Inc. · $257.66 ·
Open Payments source
-
2025-08-02 · UCB, Inc. · $7.57 ·
Open Payments source
-
2025-08-02 · UCB, Inc. · $9.47 ·
Open Payments source
-
2025-08-02 · UCB, Inc. · $10.48 ·
Open Payments source
-
2025-08-02 · UCB, Inc. · $26.16 ·
Open Payments source
-
2025-08-02 · UCB, Inc. · $30.40 ·
Open Payments source
-
2025-08-19 · UCB, Inc. · $9,000.00 ·
Open Payments source
-
2025-10-22 · UCB, Inc. · $15.52 ·
Open Payments source
-
2025-10-24 · UCB, Inc. · $24.09 ·
Open Payments source
-
2025-11-11 · UCB, Inc. · $120.04 ·
Open Payments source
-
2025-11-11 · UCB, Inc. · $2,075.00 ·
Open Payments source
-
2025-12-03 · UCB, Inc. · $4,500.00 ·
Open Payments source
|
DUPIXENT Normalized: dupixent |
Biological |
GENZYME CORPORATION, Regeneron Healthcare Solutions, Inc., Regeneron Pharmaceuticals, Inc. |
$87,793.58 |
38 |
2025 |
Source payment records
-
2025-01-06 · GENZYME CORPORATION · $72.69 ·
Open Payments source
-
2025-03-05 · GENZYME CORPORATION · $108.34 ·
Open Payments source
-
2025-04-07 · Regeneron Healthcare Solutions, Inc. · $15.14 ·
Open Payments source
-
2025-04-07 · Regeneron Pharmaceuticals, Inc. · $48.14 ·
Open Payments source
-
2025-05-03 · Regeneron Healthcare Solutions, Inc. · $7.38 ·
Open Payments source
-
2025-05-28 · Regeneron Healthcare Solutions, Inc. · $53.02 ·
Open Payments source
-
2025-05-29 · Regeneron Healthcare Solutions, Inc. · $119.19 ·
Open Payments source
-
2025-06-04 · Regeneron Healthcare Solutions, Inc. · $5,253.00 ·
Open Payments source
-
2025-06-04 · Regeneron Healthcare Solutions, Inc. · $5,253.00 ·
Open Payments source
-
2025-06-05 · Regeneron Healthcare Solutions, Inc. · $256.32 ·
Open Payments source
-
2025-06-05 · Regeneron Healthcare Solutions, Inc. · $143.95 ·
Open Payments source
-
2025-06-05 · Regeneron Healthcare Solutions, Inc. · $68.14 ·
Open Payments source
-
2025-06-05 · Regeneron Healthcare Solutions, Inc. · $67.58 ·
Open Payments source
-
2025-06-05 · Regeneron Healthcare Solutions, Inc. · $26.50 ·
Open Payments source
-
2025-06-05 · Regeneron Healthcare Solutions, Inc. · $59.63 ·
Open Payments source
-
2025-06-05 · Regeneron Healthcare Solutions, Inc. · $6.63 ·
Open Payments source
-
2025-06-05 · Regeneron Healthcare Solutions, Inc. · $26.90 ·
Open Payments source
-
2025-06-05 · Regeneron Healthcare Solutions, Inc. · $46.38 ·
Open Payments source
-
2025-06-17 · Regeneron Healthcare Solutions, Inc. · $5,253.00 ·
Open Payments source
-
2025-06-27 · Regeneron Healthcare Solutions, Inc. · $6,208.00 ·
Open Payments source
-
2025-07-31 · Regeneron Healthcare Solutions, Inc. · $106.72 ·
Open Payments source
-
2025-08-01 · Regeneron Healthcare Solutions, Inc. · $1,194.00 ·
Open Payments source
-
2025-08-05 · Regeneron Healthcare Solutions, Inc. · $6,208.00 ·
Open Payments source
-
2025-08-05 · Regeneron Healthcare Solutions, Inc. · $5,253.00 ·
Open Payments source
-
2025-08-18 · GENZYME CORPORATION · $6,208.00 ·
Open Payments source
-
2025-09-05 · Regeneron Healthcare Solutions, Inc. · $955.00 ·
Open Payments source
-
2025-09-05 · Regeneron Healthcare Solutions, Inc. · $1,910.00 ·
Open Payments source
-
2025-09-05 · Regeneron Healthcare Solutions, Inc. · $3,581.25 ·
Open Payments source
-
2025-09-05 · Regeneron Healthcare Solutions, Inc. · $238.75 ·
Open Payments source
-
2025-09-30 · Regeneron Healthcare Solutions, Inc. · $11,938.00 ·
Open Payments source
-
2025-09-30 · Regeneron Pharmaceuticals, Inc. · $74.90 ·
Open Payments source
-
2025-10-07 · Regeneron Healthcare Solutions, Inc. · $4,298.00 ·
Open Payments source
-
2025-10-24 · Regeneron Healthcare Solutions, Inc. · $11,938.00 ·
Open Payments source
-
2025-10-24 · GENZYME CORPORATION · $49.99 ·
Open Payments source
-
2025-10-29 · Regeneron Healthcare Solutions, Inc. · $124.52 ·
Open Payments source
-
2025-11-04 · Regeneron Healthcare Solutions, Inc. · $5,253.00 ·
Open Payments source
-
2025-12-17 · Regeneron Healthcare Solutions, Inc. · $116.52 ·
Open Payments source
-
2025-12-19 · Regeneron Healthcare Solutions, Inc. · $5,253.00 ·
Open Payments source
|
ANZUPGO Normalized: anzupgo |
Drug |
LEO Pharma Inc. |
$58,002.21 |
31 |
2025 |
Source payment records
-
2025-09-06 · LEO Pharma Inc. · $15.09 ·
Open Payments source
-
2025-09-06 · LEO Pharma Inc. · $17.85 ·
Open Payments source
-
2025-09-06 · LEO Pharma Inc. · $30.19 ·
Open Payments source
-
2025-09-06 · LEO Pharma Inc. · $35.21 ·
Open Payments source
-
2025-09-06 · LEO Pharma Inc. · $69.27 ·
Open Payments source
-
2025-09-06 · LEO Pharma Inc. · $1.53 ·
Open Payments source
-
2025-10-02 · LEO Pharma Inc. · $5,875.00 ·
Open Payments source
-
2025-10-13 · LEO Pharma Inc. · $19.99 ·
Open Payments source
-
2025-10-23 · LEO Pharma Inc. · $4,275.00 ·
Open Payments source
-
2025-10-23 · LEO Pharma Inc. · $4,275.00 ·
Open Payments source
-
2025-10-30 · LEO Pharma Inc. · $2.34 ·
Open Payments source
-
2025-10-30 · LEO Pharma Inc. · $121.95 ·
Open Payments source
-
2025-10-30 · LEO Pharma Inc. · $121.95 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $681.65 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $293.30 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $477.61 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $528.61 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $114.75 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $293.30 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $477.61 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $528.61 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $114.75 ·
Open Payments source
-
2025-11-05 · LEO Pharma Inc. · $681.65 ·
Open Payments source
-
2025-11-06 · LEO Pharma Inc. · $4,275.00 ·
Open Payments source
-
2025-11-06 · LEO Pharma Inc. · $4,275.00 ·
Open Payments source
-
2025-11-13 · LEO Pharma Inc. · $3,800.00 ·
Open Payments source
-
2025-11-13 · LEO Pharma Inc. · $3,800.00 ·
Open Payments source
-
2025-11-13 · LEO Pharma Inc. · $7,600.00 ·
Open Payments source
-
2025-11-13 · LEO Pharma Inc. · $3,800.00 ·
Open Payments source
-
2025-11-13 · LEO Pharma Inc. · $7,600.00 ·
Open Payments source
-
2025-11-13 · LEO Pharma Inc. · $3,800.00 ·
Open Payments source
|
EBGLYSS Normalized: ebglyss |
Drug |
Lilly USA, LLC |
$54,885.86 |
32 |
2025 |
Source payment records
-
2025-02-11 · Lilly USA, LLC · $25.98 ·
Open Payments source
-
2025-02-14 · Lilly USA, LLC · $1,200.00 ·
Open Payments source
-
2025-02-14 · Lilly USA, LLC · $3,200.00 ·
Open Payments source
-
2025-02-17 · Lilly USA, LLC · $39.12 ·
Open Payments source
-
2025-02-24 · Lilly USA, LLC · $15.24 ·
Open Payments source
-
2025-02-26 · Lilly USA, LLC · $30.50 ·
Open Payments source
-
2025-03-03 · Lilly USA, LLC · $3,200.00 ·
Open Payments source
-
2025-03-03 · Lilly USA, LLC · $1,200.00 ·
Open Payments source
-
2025-03-03 · Lilly USA, LLC · $3,200.00 ·
Open Payments source
-
2025-03-03 · Lilly USA, LLC · $1,200.00 ·
Open Payments source
-
2025-04-30 · Lilly USA, LLC · $122.58 ·
Open Payments source
-
2025-05-06 · Lilly USA, LLC · $32.51 ·
Open Payments source
-
2025-05-07 · Lilly USA, LLC · $1,200.00 ·
Open Payments source
-
2025-05-07 · Lilly USA, LLC · $3,200.00 ·
Open Payments source
-
2025-06-12 · Lilly USA, LLC · $6,400.00 ·
Open Payments source
-
2025-06-23 · Lilly USA, LLC · $1,600.00 ·
Open Payments source
-
2025-07-10 · Lilly USA, LLC · $102.91 ·
Open Payments source
-
2025-07-11 · Lilly USA, LLC · $31.30 ·
Open Payments source
-
2025-07-11 · Lilly USA, LLC · $23.47 ·
Open Payments source
-
2025-07-14 · Lilly USA, LLC · $2,800.00 ·
Open Payments source
-
2025-07-14 · Lilly USA, LLC · $3,200.00 ·
Open Payments source
-
2025-07-15 · Lilly USA, LLC · $2,800.00 ·
Open Payments source
-
2025-07-15 · Lilly USA, LLC · $3,200.00 ·
Open Payments source
-
2025-07-15 · Lilly USA, LLC · $3,200.00 ·
Open Payments source
-
2025-08-05 · Lilly USA, LLC · $2,400.00 ·
Open Payments source
-
2025-08-11 · Lilly USA, LLC · $31.72 ·
Open Payments source
-
2025-08-13 · Lilly USA, LLC · $1,200.00 ·
Open Payments source
-
2025-08-13 · Lilly USA, LLC · $3,200.00 ·
Open Payments source
-
2025-09-24 · Lilly USA, LLC · $30.53 ·
Open Payments source
-
2025-10-02 · Lilly USA, LLC · $3,200.00 ·
Open Payments source
-
2025-10-02 · Lilly USA, LLC · $1,200.00 ·
Open Payments source
-
2025-10-28 · Lilly USA, LLC · $2,400.00 ·
Open Payments source
|
OPZELURA Normalized: opzelura |
Drug |
Incyte Corporation |
$37,172.87 |
34 |
2025 |
Source payment records
|
ADBRY Normalized: adbry |
Biological |
LEO Pharma Inc. |
$24,078.12 |
16 |
2025 |
Source payment records
|
VTAMA Normalized: vtama |
Drug |
Organon LLC |
$17,373.07 |
10 |
2025 |
Source payment records
|
Leqselvi Normalized: leqselvi |
Biological |
SUN PHARMACEUTICAL INDUSTRIES INC. |
$11,297.72 |
7 |
2025 |
Source payment records
|
AKLIEF Normalized: aklief |
Drug |
Galderma Laboratories, L.P. |
$10,282.03 |
7 |
2025 |
Source payment records
-
2025-06-04 · Galderma Laboratories, L.P. · $22.95 ·
Open Payments source
-
2025-06-12 · Galderma Laboratories, L.P. · $2,600.00 ·
Open Payments source
-
2025-07-07 · Galderma Laboratories, L.P. · $3,600.00 ·
Open Payments source
-
2025-08-06 · Galderma Laboratories, L.P. · $86.47 ·
Open Payments source
-
2025-10-09 · Galderma Laboratories, L.P. · $10.04 ·
Open Payments source
-
2025-11-12 · Galderma Laboratories, L.P. · $12.57 ·
Open Payments source
-
2025-12-24 · Galderma Laboratories, L.P. · $3,950.00 ·
Open Payments source
|
Klisyri Normalized: klisyri |
Drug |
Almirall LLC |
$10,212.34 |
6 |
2025 |
Source payment records
|
Seysara Normalized: seysara |
Drug |
Almirall LLC |
$10,160.17 |
5 |
2025 |
Source payment records
|
Winlevi Normalized: winlevi |
Drug |
SUN PHARMACEUTICAL INDUSTRIES INC. |
$10,145.51 |
4 |
2025 |
Source payment records
|
ZELSUVMI Normalized: zelsuvmi |
Drug |
LNHC, Inc |
$9,329.16 |
5 |
2025 |
Source payment records
|
RINVOQ Normalized: rinvoq |
Biological |
ABBVIE INC. |
$9,053.35 |
5 |
2025 |
Source payment records
|
CIBINQO Normalized: cibinqo |
Drug |
PFIZER INC. |
$5,641.49 |
3 |
2025 |
Source payment records
|
LITFULO Normalized: litfulo |
Drug |
PFIZER INC. |
$4,218.93 |
2 |
2025 |
Source payment records
|
Unloxcyt Normalized: unloxcyt |
Drug |
SUN PHARMACEUTICAL INDUSTRIES INC. |
$3,223.36 |
2 |
2025 |
Source payment records
|
TREMFYA Normalized: tremfya |
Drug |
Janssen Biotech, Inc., Janssen Scientific Affairs, LLC |
$2,748.56 |
5 |
2025 |
Source payment records
|
Sotyktu Normalized: sotyktu |
Drug |
E.R. Squibb & Sons, L.L.C. |
$2,539.29 |
24 |
2025 |
Source payment records
-
2025-01-31 · E.R. Squibb & Sons, L.L.C. · $4.85 ·
Open Payments source
-
2025-02-13 · E.R. Squibb & Sons, L.L.C. · $4.89 ·
Open Payments source
-
2025-02-23 · E.R. Squibb & Sons, L.L.C. · $0.52 ·
Open Payments source
-
2025-03-05 · E.R. Squibb & Sons, L.L.C. · $1.52 ·
Open Payments source
-
2025-03-14 · E.R. Squibb & Sons, L.L.C. · $1.49 ·
Open Payments source
-
2025-03-24 · E.R. Squibb & Sons, L.L.C. · $7.35 ·
Open Payments source
-
2025-04-04 · E.R. Squibb & Sons, L.L.C. · $2.43 ·
Open Payments source
-
2025-04-11 · E.R. Squibb & Sons, L.L.C. · $0.32 ·
Open Payments source
-
2025-04-17 · E.R. Squibb & Sons, L.L.C. · $1.90 ·
Open Payments source
-
2025-04-19 · E.R. Squibb & Sons, L.L.C. · $0.62 ·
Open Payments source
-
2025-04-24 · E.R. Squibb & Sons, L.L.C. · $0.99 ·
Open Payments source
-
2025-04-30 · E.R. Squibb & Sons, L.L.C. · $6.54 ·
Open Payments source
-
2025-05-01 · E.R. Squibb & Sons, L.L.C. · $24.82 ·
Open Payments source
-
2025-05-14 · E.R. Squibb & Sons, L.L.C. · $5.43 ·
Open Payments source
-
2025-05-14 · E.R. Squibb & Sons, L.L.C. · $0.62 ·
Open Payments source
-
2025-05-20 · E.R. Squibb & Sons, L.L.C. · $2,350.00 ·
Open Payments source
-
2025-05-29 · E.R. Squibb & Sons, L.L.C. · $1.30 ·
Open Payments source
-
2025-05-29 · E.R. Squibb & Sons, L.L.C. · $3.29 ·
Open Payments source
-
2025-06-05 · E.R. Squibb & Sons, L.L.C. · $6.40 ·
Open Payments source
-
2025-06-10 · E.R. Squibb & Sons, L.L.C. · $2.43 ·
Open Payments source
-
2025-09-02 · E.R. Squibb & Sons, L.L.C. · $11.43 ·
Open Payments source
-
2025-09-11 · E.R. Squibb & Sons, L.L.C. · $72.15 ·
Open Payments source
-
2025-09-27 · E.R. Squibb & Sons, L.L.C. · $8.00 ·
Open Payments source
-
2025-10-22 · E.R. Squibb & Sons, L.L.C. · $20.00 ·
Open Payments source
|
YCANTH Normalized: ycanth |
Drug |
Verrica Pharmaceuticals Inc. |
$101.80 |
1 |
2025 |
Source payment records
|
Cabtreo Normalized: cabtreo |
Drug |
Ortho Dermatologics, a division of Bausch Health US, LLC |
$67.23 |
1 |
2025 |
Source payment records
-
2025-01-02 · Ortho Dermatologics, a division of Bausch Health US, LLC · $67.23 ·
Open Payments source
|
TALTZ Normalized: taltz |
Drug |
Lilly USA, LLC |
$39.12 |
1 |
2025 |
Source payment records
|